Carcinogenesis Advance Access published online on June 15, 2005
Carcinogenesis, doi:10.1093/carcin/bgi157
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Dermatology, University of Wisconsin, Madison, WI, USA
* To whom correspondence should be addressed. Pancreatic cancer is an exceptionally aggressive disease, the treatment of which has largely been unsuccessful due to higher resistance offered by pancreatic cancer cells to conventional approaches such as surgery, radiation and/or chemotherapy. The aberration of Ras oncoprotein has been linked to the induction of multiple signaling pathways and to the resistance offered by pancreatic cancer cells to the apoptosis. Therefore, there is a need for development of new and effective chemotherapeutic agents which can target multiple pathways to induce responsiveness of pancreatic cancer cells to death signals. In this study, human pancreatic adenocarcinoma cells AsPC-1 were used to investigate the effect of Lupeol on cell growth and its effects on the modulation of multiple Ras-induced signaling pathways. Lupeol caused a dose-dependent inhibition of cell growth as assessed by MTT assay and induction of apoptosis as assessed by flow cytometry, fluorescence microscopy and western blotting. Lupeol treatment to cells was found to significantly reduce the expression of Ras oncoprotein and modulate the protein expression of various signaling molecules involved in PKC
Received April 12, 2005
Revised May 26, 2005
Accepted June 7, 2005
MOLECULAR EPIDEMIOLOGY AND CANCER PREVENTION
Lupeol, a fruit and vegetable based triterpene, induces apoptotic death of human pancreatic adenocarcinoma cells via inhibition of Ras signaling pathway
Hasan Mukhtar, E-mail: hmukhtar{at}wisc.edu
![]()
Abstract
/ODC, PI3K/Akt and MAPKs pathways along with a significant reduction in the activation of NF
B signaling pathway. Our data suggests that Lupeol can adopt a multi-prong strategy to target multiple signaling pathways leading to induction of apoptosis and inhibition of growth of pancreatic cancer cells. Lupeol could be a potential agent against pancreatic cancer however, further in-depth in vivo studies are warranted.
; NF
B; Pancreatic cancer; chemoprevention.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. Saleem, I. Murtaza, R. S. Tarapore, Y. Suh, V. M. Adhami, J. J. Johnson, I. A. Siddiqui, N. Khan, M. Asim, B. B. Hafeez, et al. Lupeol inhibits proliferation of human prostate cancer cells by targeting {beta}-catenin signaling Carcinogenesis, May 1, 2009; 30(5): 808 - 817. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Murtaza, M. Saleem, V. M. Adhami, B. B. Hafeez, and H. Mukhtar Suppression of cFLIP by Lupeol, a Dietary Triterpene, Is Sufficient to Overcome Resistance to TRAIL-Mediated Apoptosis in Chemoresistant Human Pancreatic Cancer Cells Cancer Res., February 1, 2009; 69(3): 1156 - 1165. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Saleem, N. Maddodi, M. Abu Zaid, N. Khan, B. bin Hafeez, M. Asim, Y. Suh, J.-M. Yun, V. Setaluri, and H. Mukhtar Lupeol Inhibits Growth of Highly Aggressive Human Metastatic Melanoma Cells In vitro and In vivo by Inducing Apoptosis Clin. Cancer Res., April 1, 2008; 14(7): 2119 - 2127. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-H. Kweon, V. M. Adhami, J.-S. Lee, and H. Mukhtar Constitutive Overexpression of Nrf2-dependent Heme Oxygenase-1 in A549 Cells Contributes to Resistance to Apoptosis Induced by Epigallocatechin 3-Gallate J. Biol. Chem., November 3, 2006; 281(44): 33761 - 33772. [Abstract] [Full Text] [PDF] |
||||



